US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharvaris N.V.

22.99

-0.0100-0.04%

Post-market: 22.990.00000.00%16:11 EDT

Volume:559.45K

Turnover:12.95M

Market Cap:1.49B

PE:-6.33

High:23.49

Open:23.27

Low:22.54

Close:23.00

52wk High:26.33

52wk Low:11.51

Shares:64.95M

Float Shares:33.91M

Volume Ratio:2.78

T/O Rate:1.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.6336

EPS(LYR):-2.5724

ROE:-65.09%

ROA:-36.84%

PB:6.97

PE(LYR):-8.94

Loading ...

Overview Company News Filings

US Stock Futures Edge Higher in Wednesday's Premarket Ahead of Housing, Oil Data

MT Newswires Live

BRIEF-Pharvaris Prices Upsized $175 Million Public Offering Of Ordinary Shares, Pre-Funded Warrants

Stocks to Watch: Lulu's, Manhattan Associates, Pharvaris, Usana Health Sciences

Pharvaris Stock Falls on Plans for $150M Share Offering

Pharvaris NV Announces $150 Million Public Offering of Ordinary Shares to Support Clinical Programs and Expansion Efforts

Pharvaris Announces Proposed Public Offering of Ordinary Shares

Pharvaris NV Concluded Annual General Meeting of Shareholders

Pharvaris Expects to Release Topline Data From Phase 3 Hereditary Angioedema Study in Q4

MT Newswires Live

BRIEF-Pharvaris NV - Expects Rapide-3 Data Announcement In Q4 2025

Pharvaris NV to Announce Third Quarter 2025 Financial Results

Pharvaris NV Conducted Annual General Meeting of Shareholders

Pharvaris NV to Present Promising Clinical Trial Data on Oral Deucrictibant for Hereditary Angioedema at 2025 US HAEA National Summit

Pharvaris Unveils Promising Data on Deucrictibant for Bradykinin-Mediated Angioedema at EAACI Congress 2025

Guggenheim Initiates Coverage on Pharvaris With Buy Rating, $32 Price Target

MT Newswires Live

Press Release: Pharvaris Announces Annual Meeting of Shareholders

Pharvaris NV Publishes 2024 Annual Report

Pharvaris Price Target Maintained With a $27.00/Share by Wedbush

Pharvaris NV to Present Deucrictibant Clinical and Biomarker Data at C1-Inhibitor Deficiency and Angioedema Workshop

Stock Track | Pharvaris N.V. Plummets 5.15% After Q1 Earnings Miss and Conflicting Analyst Reports

Stock Track | Pharvaris N.V. Plummets 5.15% After Disappointing Q1 Results and Analyst Price Target Cut

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PHVS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","market":"US","secType":"STK","nameCN":"Pharvaris N.V.","latestPrice":22.99,"timestamp":1761336000000,"preClose":23,"halted":0,"volume":559454,"hourTrading":{"tag":"盘后","latestPrice":22.99,"preClose":22.99,"latestTime":"16:11 EDT","volume":7769,"amount":178609.31,"timestamp":1761336663232},"delay":0,"floatShares":33905700,"shares":64954600,"eps":-3.633627,"marketStatus":"Market Closed","change":-0.01,"latestTime":"10-24 16:00:00 EDT","open":23.27,"high":23.485,"low":22.54,"amount":12951630.0088,"amplitude":0.041087,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.633627,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1761552000000},"marketStatusCode":7,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":23,"preHourTrading":{"tag":"盘前","latestPrice":23.27,"preClose":23,"latestTime":"09:29 EDT","volume":104,"amount":2416.870144,"timestamp":1761312596062},"postHourTrading":{"tag":"盘后","latestPrice":22.99,"preClose":22.99,"latestTime":"16:11 EDT","volume":7769,"amount":178609.31,"timestamp":1761336663232},"volumeRatio":2.775551312781592,"impliedVol":0.2284,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","floatShares":33905700,"roa":"-36.84%","roe":"-65.09%","lyrEps":-2.572355,"volumeRatio":2.775551312781592,"shares":64954600,"dividePrice":0,"high":23.485,"amplitude":0.041087,"preClose":23,"low":22.54,"week52Low":11.51,"pbRate":"6.97","week52High":26.33,"institutionHeld":0,"latestPrice":22.99,"eps":-3.633627,"divideRate":0,"volume":559454,"delay":0,"ttmEps":-3.633627,"open":23.27,"prevYearClose":19.17,"prevWeekClose":21.12,"prevMonthClose":24.95,"prevQuarterClose":24.95,"fiveDayClose":21.12,"twentyDayClose":24.165,"sixtyDayClose":19.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHVS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"PHVS","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.94},{"market":"US","date":"2025-05-13","symbol":"PHVS","fiscalQuarterEnding":"2025/03","expectedEps":-0.8,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.89},{"market":"US","date":"2025-04-07","symbol":"PHVS","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-11-13","symbol":"PHVS","fiscalQuarterEnding":"2024/09","expectedEps":-0.66,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2024-08-14","symbol":"PHVS","fiscalQuarterEnding":"2024/06","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.59}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHVS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHVS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.4167,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4167,"analysts":12,"updateTime":1760587200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHVS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHVS","date":"2025-10-24","current":-6.327012,"percent":0.514335,"low":-57.487033,"twenty":-13.347233,"median":-8.60362,"eighty":-5.824758,"high":-1.271834,"avg":-10.995488,"sd":8.620759,"marketCap":1663029766},"quantilePoints":[{"date":"2021-02-05","current":-40.655528,"twenty":-35.191346,"median":-26.995074,"eighty":-13.361825,"marketCap":923353504},{"date":"2021-02-12","current":-38.556139,"twenty":-42.255967,"median":-39.971365,"eighty":-31.6195,"marketCap":882252961},{"date":"2021-02-19","current":-51.857545,"twenty":-43.656687,"median":-39.971365,"eighty":-36.938628,"marketCap":1187915404},{"date":"2021-02-26","current":-55.014362,"twenty":-51.321142,"median":-43.322927,"eighty":-38.567599,"marketCap":1256722534},{"date":"2021-03-05","current":-42.283482,"twenty":-54.697812,"median":-44.160099,"eighty":-38.836179,"marketCap":951060091},{"date":"2021-03-12","current":-45.331857,"twenty":-53.116798,"median":-43.740127,"eighty":-39.776385,"marketCap":1022182845},{"date":"2021-03-19","current":-48.948372,"twenty":-52.354204,"median":-44.955963,"eighty":-40.021819,"marketCap":1099921670},{"date":"2021-03-26","current":-38.967887,"twenty":-51.682886,"median":-44.895337,"eighty":-39.792548,"marketCap":867697606},{"date":"2021-04-01","current":-41.621102,"twenty":-50.984249,"median":-43.918021,"eighty":-39.727138,"marketCap":924595810},{"date":"2021-04-09","current":-41.75527,"twenty":-50.647351,"median":-43.315034,"eighty":-39.727138,"marketCap":936835540},{"date":"2021-04-16","current":-40.837748,"twenty":-50.494041,"median":-42.658519,"eighty":-39.747341,"marketCap":923603399},{"date":"2021-04-23","current":-37.900499,"twenty":-49.17553,"median":-42.026105,"eighty":-38.829918,"marketCap":863066357},{"date":"2021-04-30","current":-25.541319,"twenty":-48.948372,"median":-41.646601,"eighty":-37.900499,"marketCap":798399091},{"date":"2021-05-07","current":-23.738176,"twenty":-48.895342,"median":-41.104912,"eighty":-36.326921,"marketCap":749700059},{"date":"2021-05-14","current":-22.435939,"twenty":-48.511867,"median":-40.837748,"eighty":-33.58931,"marketCap":707626746},{"date":"2021-05-21","current":-21.234553,"twenty":-47.818543,"median":-40.295032,"eighty":-26.156611,"marketCap":672510437},{"date":"2021-05-28","current":-19.380576,"twenty":-45.432957,"median":-39.747341,"eighty":-24.421758,"marketCap":679136156},{"date":"2021-06-04","current":-19.347354,"twenty":-45.352077,"median":-38.967887,"eighty":-23.463638,"marketCap":676817154},{"date":"2021-06-11","current":-19.412718,"twenty":-44.982641,"median":-38.721678,"eighty":-21.843417,"marketCap":675160725},{"date":"2021-06-18","current":-18.174436,"twenty":-44.643123,"median":-38.260176,"eighty":-21.113619,"marketCap":619504689},{"date":"2021-06-25","current":-17.828602,"twenty":-44.050431,"median":-37.439407,"eighty":-19.442186,"marketCap":612216398},{"date":"2021-07-02","current":-15.85879,"twenty":-43.775706,"median":-36.326921,"eighty":-19.370104,"marketCap":539996065},{"date":"2021-07-09","current":-14.490358,"twenty":-43.489807,"median":-35.672294,"eighty":-19.194795,"marketCap":494278607},{"date":"2021-07-16","current":-13.876053,"twenty":-43.313455,"median":-30.292192,"eighty":-19.061523,"marketCap":471088592},{"date":"2021-07-23","current":-14.202744,"twenty":-43.303543,"median":-26.3148,"eighty":-18.384979,"marketCap":480364598},{"date":"2021-07-30","current":-12.988167,"twenty":-42.915569,"median":-25.765358,"eighty":-18.050979,"marketCap":588695097},{"date":"2021-08-06","current":-11.844555,"twenty":-42.476534,"median":-24.421758,"eighty":-16.85205,"marketCap":532376489},{"date":"2021-08-13","current":-12.144906,"twenty":-42.312174,"median":-23.50716,"eighty":-15.514047,"marketCap":547615642},{"date":"2021-08-20","current":-12.372065,"twenty":-41.974629,"median":-22.435939,"eighty":-14.676752,"marketCap":552253645},{"date":"2021-08-27","current":-14.6624,"twenty":-41.760653,"median":-21.796739,"eighty":-14.375312,"marketCap":660584144},{"date":"2021-09-03","current":-13.869765,"twenty":-41.690069,"median":-21.159134,"eighty":-14.206363,"marketCap":629774552},{"date":"2021-09-10","current":-14.483783,"twenty":-41.636401,"median":-21.097683,"eighty":-14.200739,"marketCap":654620997},{"date":"2021-09-17","current":-13.408551,"twenty":-41.415194,"median":-19.619941,"eighty":-14.095163,"marketCap":601399913},{"date":"2021-09-24","current":-13.735189,"twenty":-41.105195,"median":-19.412718,"eighty":-13.917369,"marketCap":614535400},{"date":"2021-10-01","current":-13.275187,"twenty":-41.073352,"median":-19.361573,"eighty":-13.752501,"marketCap":588032525},{"date":"2021-10-08","current":-11.567624,"twenty":-40.951984,"median":-19.206349,"eighty":-13.609193,"marketCap":511505475},{"date":"2021-10-15","current":-11.808567,"twenty":-40.76486,"median":-19.158657,"eighty":-13.358075,"marketCap":523431769},{"date":"2021-10-22","current":-11.367098,"twenty":-40.543106,"median":-18.996962,"eighty":-13.26419,"marketCap":505211043},{"date":"2021-10-29","current":-13.069107,"twenty":-40.31092,"median":-18.615071,"eighty":-13.235325,"marketCap":577431375},{"date":"2021-11-05","current":-11.318661,"twenty":-40.118706,"median":-18.174436,"eighty":-12.989342,"marketCap":499744825},{"date":"2021-11-12","current":-12.526544,"twenty":-39.882961,"median":-18.037659,"eighty":-12.809718,"marketCap":547946928},{"date":"2021-11-19","current":-11.924212,"twenty":-39.73926,"median":-17.467833,"eighty":-12.433857,"marketCap":515812193},{"date":"2021-11-26","current":-10.362749,"twenty":-39.575288,"median":-16.707882,"eighty":-12.294384,"marketCap":448064220},{"date":"2021-12-03","current":-11.26034,"twenty":-38.958466,"median":-15.822297,"eighty":-12.166304,"marketCap":485665173},{"date":"2021-12-10","current":-11.449501,"twenty":-38.90261,"median":-15.106412,"eighty":-12.085176,"marketCap":494941179},{"date":"2021-12-17","current":-11.918983,"twenty":-38.786622,"median":-14.824901,"eighty":-12.032102,"marketCap":513493191},{"date":"2021-12-23","current":-12.067526,"twenty":-38.613439,"median":-14.809703,"eighty":-12.04158,"marketCap":521775339},{"date":"2021-12-31","current":-10.970608,"twenty":-38.556139,"median":-14.6624,"eighty":-12.029733,"marketCap":476720453},{"date":"2022-01-07","current":-14.755715,"twenty":-38.260176,"median":-14.556631,"eighty":-12.04158,"marketCap":639381844},{"date":"2022-01-14","current":-13.648303,"twenty":-37.900499,"median":-14.301086,"eighty":-12.059144,"marketCap":595652102},{"date":"2022-01-21","current":-13.462107,"twenty":-37.887735,"median":-14.301086,"eighty":-12.06585,"marketCap":583394522},{"date":"2022-01-28","current":-13.205088,"twenty":-37.172324,"median":-14.201073,"eighty":-12.067932,"marketCap":563186081},{"date":"2022-02-04","current":-13.024782,"twenty":-36.626254,"median":-14.120681,"eighty":-12.079807,"marketCap":569480513},{"date":"2022-02-11","current":-13.759795,"twenty":-36.368387,"median":-14.065459,"eighty":-12.092451,"marketCap":599627533},{"date":"2022-02-18","current":-13.388638,"twenty":-36.150333,"median":-14.023379,"eighty":-12.098608,"marketCap":579750377},{"date":"2022-02-25","current":-13.305926,"twenty":-35.845851,"median":-13.954525,"eighty":-12.116084,"marketCap":572793372},{"date":"2022-03-04","current":-14.115965,"twenty":-35.670778,"median":-13.938377,"eighty":-12.137788,"marketCap":588695097},{"date":"2022-03-11","current":-13.463028,"twenty":-34.421493,"median":-13.892451,"eighty":-12.149516,"marketCap":563186081},{"date":"2022-03-18","current":-14.218002,"twenty":-29.632768,"median":-13.881977,"eighty":-12.157248,"marketCap":600952677},{"date":"2022-03-25","current":-13.943073,"twenty":-26.658074,"median":-13.883771,"eighty":-12.178203,"marketCap":585382238},{"date":"2022-04-01","current":-12.747151,"twenty":-26.362243,"median":-13.880091,"eighty":-12.194172,"marketCap":601209361},{"date":"2022-04-08","current":-13.160374,"twenty":-26.219887,"median":-13.869765,"eighty":-12.198767,"marketCap":611652204},{"date":"2022-04-14","current":-12.64181,"twenty":-26.010325,"median":-13.786628,"eighty":-12.200601,"marketCap":583804624},{"date":"2022-04-22","current":-12.23556,"twenty":-25.770465,"median":-13.764494,"eighty":-12.203958,"marketCap":563581977},{"date":"2022-04-29","current":-12.580911,"twenty":-25.660418,"median":-13.730786,"eighty":-12.217679,"marketCap":566542439},{"date":"2022-05-06","current":-12.310085,"twenty":-25.093495,"median":-13.707219,"eighty":-12.233824,"marketCap":557283119},{"date":"2022-05-13","current":-10.422165,"twenty":-24.148325,"median":-13.655613,"eighty":-12.198139,"marketCap":571878572},{"date":"2022-05-20","current":-10.134271,"twenty":-23.650401,"median":-13.608097,"eighty":-12.152353,"marketCap":563590477},{"date":"2022-05-27","current":-10.266885,"twenty":-23.509475,"median":-13.570194,"eighty":-12.096742,"marketCap":579835143},{"date":"2022-06-03","current":-10.984203,"twenty":-23.463638,"median":-13.4682,"eighty":-12.07039,"marketCap":620612572},{"date":"2022-06-10","current":-12.843347,"twenty":-23.155882,"median":-13.459721,"eighty":-12.067627,"marketCap":712444667},{"date":"2022-06-17","current":-16.528573,"twenty":-22.410251,"median":-13.457335,"eighty":-12.07039,"marketCap":911690477},{"date":"2022-06-24","current":-12.484354,"twenty":-22.307498,"median":-13.442896,"eighty":-12.079819,"marketCap":694210858},{"date":"2022-07-01","current":-14.299351,"twenty":-21.874535,"median":-13.402807,"eighty":-12.068033,"marketCap":784053810},{"date":"2022-07-08","current":-14.094213,"twenty":-21.750061,"median":-13.450115,"eighty":-12.077462,"marketCap":756209125},{"date":"2022-07-15","current":-14.396825,"twenty":-21.331431,"median":-13.463028,"eighty":-12.082165,"marketCap":765820001},{"date":"2022-07-22","current":-13.29424,"twenty":-21.174218,"median":-13.473474,"eighty":-12.092451,"marketCap":716422953},{"date":"2022-07-29","current":-13.469033,"twenty":-21.125909,"median":-13.4682,"eighty":-12.098608,"marketCap":724213762},{"date":"2022-08-05","current":-11.76507,"twenty":-21.101667,"median":-13.459721,"eighty":-12.082165,"marketCap":629895239},{"date":"2022-08-12","current":-10.43948,"twenty":-20.186916,"median":-13.408551,"eighty":-12.055631,"marketCap":564253524},{"date":"2022-08-19","current":-11.581834,"twenty":-19.826532,"median":-13.395996,"eighty":-12.028713,"marketCap":612987524},{"date":"2022-08-26","current":-5.820227,"twenty":-19.515891,"median":-13.372919,"eighty":-11.990749,"marketCap":306659524},{"date":"2022-09-02","current":-5.892736,"twenty":-19.429171,"median":-13.356682,"eighty":-11.943475,"marketCap":311632381},{"date":"2022-09-09","current":-5.834763,"twenty":-19.417564,"median":-13.345814,"eighty":-11.915113,"marketCap":308814429},{"date":"2022-09-16","current":-6.129031,"twenty":-19.393433,"median":-13.317212,"eighty":-11.844209,"marketCap":307945619},{"date":"2022-09-23","current":-5.527907,"twenty":-19.377706,"median":-13.304479,"eighty":-11.805952,"marketCap":269452416},{"date":"2022-09-30","current":-5.268219,"twenty":-19.358729,"median":-13.29424,"eighty":-11.739355,"marketCap":258984966},{"date":"2022-10-07","current":-3.334511,"twenty":-19.313349,"median":-13.281408,"eighty":-11.574558,"marketCap":163427280},{"date":"2022-10-14","current":-3.192899,"twenty":-19.240081,"median":-13.26552,"eighty":-11.519941,"marketCap":155998767},{"date":"2022-10-21","current":-3.776992,"twenty":-19.189017,"median":-13.2607,"eighty":-11.419826,"marketCap":185712818},{"date":"2022-10-28","current":-3.404363,"twenty":-19.175941,"median":-13.241782,"eighty":-11.34035,"marketCap":169704373},{"date":"2022-11-04","current":-2.493588,"twenty":-19.155403,"median":-13.21909,"eighty":-11.293284,"marketCap":123921098},{"date":"2022-11-11","current":-1.962841,"twenty":-19.119693,"median":-13.202703,"eighty":-11.220822,"marketCap":101635560},{"date":"2022-11-18","current":-1.709372,"twenty":-19.040002,"median":-13.169144,"eighty":-11.073401,"marketCap":88804493},{"date":"2022-11-25","current":-1.59989,"twenty":-18.960552,"median":-13.089194,"eighty":-10.924331,"marketCap":83401938},{"date":"2022-12-02","current":-1.271834,"twenty":-18.879299,"median":-13.066255,"eighty":-10.549888,"marketCap":66856614},{"date":"2022-12-09","current":-5.585763,"twenty":-18.659925,"median":-13.055482,"eighty":-10.38824,"marketCap":291250318},{"date":"2022-12-16","current":-4.830297,"twenty":-18.384979,"median":-13.024782,"eighty":-10.32247,"marketCap":253408050},{"date":"2022-12-23","current":-6.371604,"twenty":-18.295522,"median":-12.990589,"eighty":-10.187317,"marketCap":334836503},{"date":"2022-12-30","current":-7.188594,"twenty":-18.170479,"median":-12.982972,"eighty":-10.008759,"marketCap":380112075},{"date":"2023-01-06","current":-7.688928,"twenty":-18.154652,"median":-12.903124,"eighty":-9.752954,"marketCap":403763493},{"date":"2023-01-13","current":-5.706058,"twenty":-18.104257,"median":-12.846213,"eighty":-7.688928,"marketCap":305441169},{"date":"2023-01-20","current":-6.459312,"twenty":-17.9977,"median":-12.837332,"eighty":-7.374204,"marketCap":346324335},{"date":"2023-01-27","current":-5.951135,"twenty":-17.857094,"median":-12.821298,"eighty":-6.862976,"marketCap":319632020},{"date":"2023-02-03","current":-5.776873,"twenty":-17.539987,"median":-12.756949,"eighty":-6.367933,"marketCap":310171453},{"date":"2023-02-10","current":-6.06212,"twenty":-17.052096,"median":-12.693639,"eighty":-6.243368,"marketCap":320307775},{"date":"2023-02-17","current":-5.565251,"twenty":-16.755938,"median":-12.64181,"eighty":-6.151395,"marketCap":293615460},{"date":"2023-02-24","current":-5.080906,"twenty":-16.600297,"median":-12.612561,"eighty":-6.08797,"marketCap":265233759},{"date":"2023-03-03","current":-5.604926,"twenty":-16.439572,"median":-12.581052,"eighty":-6.019199,"marketCap":293953338},{"date":"2023-03-10","current":-4.059398,"twenty":-16.126823,"median":-12.554737,"eighty":-5.957727,"marketCap":214214271},{"date":"2023-03-17","current":-4.759844,"twenty":-15.898426,"median":-12.5386,"eighty":-5.915214,"marketCap":251042908},{"date":"2023-03-24","current":-4.748457,"twenty":-15.814998,"median":-12.484354,"eighty":-5.839251,"marketCap":252732295},{"date":"2023-03-31","current":-5.062872,"twenty":-15.558556,"median":-12.41617,"eighty":-5.818726,"marketCap":272160245},{"date":"2023-04-06","current":-5.515395,"twenty":-15.2868,"median":-12.393076,"eighty":-5.798276,"marketCap":298007866},{"date":"2023-04-14","current":-3.407139,"twenty":-15.104598,"median":-12.376683,"eighty":-5.751686,"marketCap":287439901},{"date":"2023-04-21","current":-3.423024,"twenty":-15.075219,"median":-12.365371,"eighty":-5.695738,"marketCap":286594490},{"date":"2023-04-28","current":-3.621546,"twenty":-14.971826,"median":-12.310085,"eighty":-5.661512,"marketCap":304686295},{"date":"2023-05-05","current":-3.635585,"twenty":-14.858222,"median":-12.26867,"eighty":-5.593428,"marketCap":305362624},{"date":"2023-05-12","current":-3.330904,"twenty":-14.826016,"median":-12.249364,"eighty":-5.568587,"marketCap":277633128},{"date":"2023-05-19","current":-3.332274,"twenty":-14.818952,"median":-12.234113,"eighty":-5.5204,"marketCap":297584839},{"date":"2023-05-26","current":-3.231497,"twenty":-14.811441,"median":-12.222059,"eighty":-5.439393,"marketCap":287439901},{"date":"2023-06-02","current":-3.434585,"twenty":-14.791955,"median":-12.201472,"eighty":-5.312927,"marketCap":305832502},{"date":"2023-06-09","current":-3.407273,"twenty":-14.764775,"median":-12.198453,"eighty":-5.28475,"marketCap":304479261},{"date":"2023-06-16","current":-4.170938,"twenty":-14.740265,"median":-12.160354,"eighty":-5.07843,"marketCap":377892593},{"date":"2023-06-23","current":-4.359744,"twenty":-14.731325,"median":-12.152393,"eighty":-5.057591,"marketCap":396297439},{"date":"2023-06-30","current":-7.00064,"twenty":-14.718305,"median":-12.136009,"eighty":-5.055831,"marketCap":632126719},{"date":"2023-07-07","current":-7.084548,"twenty":-14.696694,"median":-12.097209,"eighty":-5.062872,"marketCap":638244074},{"date":"2023-07-14","current":-6.875228,"twenty":-14.6624,"median":-12.079819,"eighty":-5.068525,"marketCap":638244074},{"date":"2023-07-21","current":-7.028003,"twenty":-14.653302,"median":-12.064139,"eighty":-5.080906,"marketCap":649663138},{"date":"2023-07-28","current":-7.498848,"twenty":-14.622905,"median":-12.04158,"eighty":-5.207419,"marketCap":683512504},{"date":"2023-08-04","current":-7.953511,"twenty":-14.601036,"median":-12.024634,"eighty":-5.228713,"marketCap":722255754},{"date":"2023-08-11","current":-7.354477,"twenty":-14.583407,"median":-11.998532,"eighty":-5.261383,"marketCap":747059362},{"date":"2023-08-18","current":-7.862758,"twenty":-14.572779,"median":-11.956319,"eighty":-5.28475,"marketCap":788698737},{"date":"2023-08-25","current":-7.637624,"twenty":-14.506463,"median":-11.943194,"eighty":-5.298861,"marketCap":762796904},{"date":"2023-08-31","current":-8.133422,"twenty":-14.4867,"median":-11.921598,"eighty":-5.305964,"marketCap":813459365},{"date":"2023-09-08","current":-7.866907,"twenty":-14.484166,"median":-11.909309,"eighty":-5.312927,"marketCap":776279656},{"date":"2023-09-15","current":-8.565073,"twenty":-14.483879,"median":-11.869315,"eighty":-5.324599,"marketCap":842467710},{"date":"2023-09-22","current":-8.218785,"twenty":-14.422991,"median":-11.843691,"eighty":-5.364732,"marketCap":808147978},{"date":"2023-09-29","current":-8.499622,"twenty":-14.407261,"median":-11.810464,"eighty":-5.391254,"marketCap":828167822},{"date":"2023-10-06","current":-8.075664,"twenty":-14.404891,"median":-11.805298,"eighty":-5.421144,"marketCap":784042452},{"date":"2023-10-13","current":-7.97887,"twenty":-14.393189,"median":-11.762441,"eighty":-5.494747,"marketCap":776279656},{"date":"2023-10-20","current":-7.871535,"twenty":-14.374592,"median":-11.67635,"eighty":-5.497417,"marketCap":767699722},{"date":"2023-10-27","current":-7.699507,"twenty":-14.37054,"median":-11.628617,"eighty":-5.497654,"marketCap":747679879},{"date":"2023-11-03","current":-7.17043,"twenty":-14.351862,"median":-11.573402,"eighty":-5.505177,"marketCap":701920236},{"date":"2023-11-10","current":-5.970942,"twenty":-14.325681,"median":-11.546094,"eighty":-5.518658,"marketCap":686476556},{"date":"2023-11-17","current":-5.487665,"twenty":-14.300392,"median":-11.499199,"eighty":-5.518658,"marketCap":639755166},{"date":"2023-11-24","current":-5.931936,"twenty":-14.283081,"median":-11.456561,"eighty":-5.501771,"marketCap":694263454},{"date":"2023-12-01","current":-6.025826,"twenty":-14.216157,"median":-11.367098,"eighty":-5.517027,"marketCap":705329046},{"date":"2023-12-08","current":-11.439876,"twenty":-14.20757,"median":-11.347894,"eighty":-5.524424,"marketCap":1324602518},{"date":"2023-12-15","current":-11.41059,"twenty":-14.202076,"median":-11.375314,"eighty":-5.532271,"marketCap":1346488162},{"date":"2023-12-22","current":-11.925452,"twenty":-14.184853,"median":-11.42744,"eighty":-5.551316,"marketCap":1406934225},{"date":"2023-12-29","current":-12.247032,"twenty":-14.141201,"median":-11.449501,"eighty":-5.556079,"marketCap":1455916379},{"date":"2024-01-05","current":-11.217845,"twenty":-14.124263,"median":-11.444688,"eighty":-5.560701,"marketCap":1319391651},{"date":"2024-01-12","current":-13.194311,"twenty":-14.118795,"median":-11.460366,"eighty":-5.568587,"marketCap":1550325393},{"date":"2024-01-19","current":-14.465426,"twenty":-14.174814,"median":-11.47464,"eighty":-5.574125,"marketCap":1686754028},{"date":"2024-01-26","current":-14.983944,"twenty":-14.20757,"median":-11.499199,"eighty":-5.577066,"marketCap":1742861042},{"date":"2024-02-02","current":-15.192524,"twenty":-14.300739,"median":-11.528223,"eighty":-5.581389,"marketCap":1768847449},{"date":"2024-02-09","current":-14.748842,"twenty":-14.393189,"median":-11.54682,"eighty":-5.589596,"marketCap":1703881432},{"date":"2024-02-16","current":-13.65194,"twenty":-14.404891,"median":-11.567624,"eighty":-5.608959,"marketCap":1576311800},{"date":"2024-02-23","current":-14.13304,"twenty":-14.396825,"median":-11.581834,"eighty":-5.625092,"marketCap":1640687216},{"date":"2024-03-01","current":-10.303743,"twenty":-14.378644,"median":-11.573402,"eighty":-5.629721,"marketCap":1195373004},{"date":"2024-03-08","current":-12.093153,"twenty":-14.358385,"median":-11.567624,"eighty":-5.636181,"marketCap":1418455194},{"date":"2024-03-15","current":-10.896325,"twenty":-14.342077,"median":-11.552539,"eighty":-5.658684,"marketCap":1273758779},{"date":"2024-03-22","current":-11.538805,"twenty":-14.301086,"median":-11.546205,"eighty":-5.665753,"marketCap":1344762225},{"date":"2024-03-28","current":-10.904189,"twenty":-14.299698,"median":-11.538805,"eighty":-5.674035,"marketCap":1264076491},{"date":"2024-04-05","current":-10.349243,"twenty":-14.288877,"median":-11.507756,"eighty":-5.680711,"marketCap":1206520668},{"date":"2024-04-12","current":-11.107813,"twenty":-14.231653,"median":-11.490879,"eighty":-5.687459,"marketCap":1200065809},{"date":"2024-04-19","current":-9.215802,"twenty":-14.210621,"median":-11.46913,"eighty":-5.702618,"marketCap":991303742},{"date":"2024-04-26","current":-11.339937,"twenty":-14.20395,"median":-11.459096,"eighty":-5.715476,"marketCap":1225406418},{"date":"2024-05-03","current":-11.733497,"twenty":-14.200071,"median":-11.46913,"eighty":-5.724599,"marketCap":1266307115},{"date":"2024-05-10","current":-9.668623,"twenty":-14.189365,"median":-11.459096,"eighty":-5.733174,"marketCap":1107009662},{"date":"2024-05-17","current":-10.115404,"twenty":-14.156013,"median":-11.42744,"eighty":-5.759289,"marketCap":1168360708},{"date":"2024-05-24","current":-9.147602,"twenty":-14.136092,"median":-11.375314,"eighty":-5.774576,"marketCap":1052116621},{"date":"2024-05-31","current":-8.827191,"twenty":-14.129207,"median":-11.35501,"eighty":-5.782121,"marketCap":1017135762},{"date":"2024-06-07","current":-7.823819,"twenty":-14.123069,"median":-11.339823,"eighty":-5.787829,"marketCap":904658844},{"date":"2024-06-14","current":-8.515887,"twenty":-14.119026,"median":-11.316994,"eighty":-5.792437,"marketCap":974082396},{"date":"2024-06-21","current":-8.52603,"twenty":-14.116428,"median":-11.288753,"eighty":-5.797709,"marketCap":970853394},{"date":"2024-06-28","current":-8.52006,"twenty":-14.116197,"median":-11.262481,"eighty":-5.798843,"marketCap":969238893},{"date":"2024-07-05","current":-7.963908,"twenty":-14.11303,"median":-11.251924,"eighty":-5.805313,"marketCap":914884019},{"date":"2024-07-12","current":-8.497692,"twenty":-14.104041,"median":-11.224936,"eighty":-5.814579,"marketCap":981616735},{"date":"2024-07-15","current":-8.709438,"twenty":-14.101747,"median":-11.224715,"eighty":-5.815211,"marketCap":1010139590},{"date":"2024-08-02","current":-7.485095,"twenty":-14.099454,"median":-11.224493,"eighty":-5.815842,"marketCap":857838309},{"date":"2024-08-09","current":-7.640912,"twenty":-14.094802,"median":-11.205504,"eighty":-5.819476,"marketCap":885822997},{"date":"2024-08-16","current":-8.240501,"twenty":-14.093907,"median":-11.162588,"eighty":-5.823431,"marketCap":1032742607},{"date":"2024-08-23","current":-7.760367,"twenty":-14.048436,"median":-11.118035,"eighty":-5.826337,"marketCap":983480417},{"date":"2024-08-30","current":-7.393035,"twenty":-14.034683,"median":-11.087899,"eighty":-5.833183,"marketCap":934333400},{"date":"2024-09-06","current":-8.155019,"twenty":-14.033224,"median":-11.020127,"eighty":-5.839251,"marketCap":1031547280},{"date":"2024-09-13","current":-8.802104,"twenty":-14.027088,"median":-10.978779,"eighty":-5.849019,"marketCap":1108238229},{"date":"2024-09-20","current":-8.962749,"twenty":-13.99324,"median":-10.957045,"eighty":-5.877056,"marketCap":1139022624},{"date":"2024-09-27","current":-8.000083,"twenty":-13.961974,"median":-10.894902,"eighty":-5.894802,"marketCap":1020205660},{"date":"2024-10-04","current":-7.688355,"twenty":-13.947654,"median":-10.874176,"eighty":-5.909483,"marketCap":966197949},{"date":"2024-10-11","current":-7.725025,"twenty":-13.936046,"median":-10.812773,"eighty":-5.924083,"marketCap":962957487},{"date":"2024-10-18","current":-9.289256,"twenty":-13.925882,"median":-10.792815,"eighty":-5.928401,"marketCap":1147663858},{"date":"2024-10-25","current":-9.347449,"twenty":-13.904362,"median":-10.773913,"eighty":-5.930655,"marketCap":1151984475},{"date":"2024-10-31","current":-10.81176,"twenty":-13.888979,"median":-10.69668,"eighty":-5.935928,"marketCap":1339391232},{"date":"2024-11-08","current":-9.795031,"twenty":-13.882336,"median":-10.614452,"eighty":-5.945603,"marketCap":1205452109},{"date":"2024-11-15","current":-7.934741,"twenty":-13.880109,"median":-10.567811,"eighty":-5.951569,"marketCap":1109858461},{"date":"2024-11-22","current":-8.193559,"twenty":-13.878421,"median":-10.530141,"eighty":-5.955891,"marketCap":1136322239},{"date":"2024-11-29","current":-8.515548,"twenty":-13.874795,"median":-10.499116,"eighty":-5.962822,"marketCap":1187704999},{"date":"2024-12-06","current":-7.575701,"twenty":-13.869107,"median":-10.430822,"eighty":-5.969,"marketCap":1058630209},{"date":"2024-12-13","current":-7.438607,"twenty":-13.864864,"median":-10.405945,"eighty":-5.972,"marketCap":1031513657},{"date":"2024-12-20","current":-7.511117,"twenty":-13.847086,"median":-10.370165,"eighty":-5.976517,"marketCap":1030971326},{"date":"2024-12-27","current":-7.680726,"twenty":-13.801742,"median":-10.357252,"eighty":-5.977661,"marketCap":1057545547},{"date":"2025-01-03","current":-7.415916,"twenty":-13.792864,"median":-10.345951,"eighty":-6.00833,"marketCap":1005481766},{"date":"2025-01-10","current":-7.387777,"twenty":-13.788234,"median":-10.323543,"eighty":-6.019199,"marketCap":1005481766},{"date":"2025-01-17","current":-6.953437,"twenty":-13.781733,"median":-10.297117,"eighty":-6.023626,"marketCap":946367682},{"date":"2025-01-24","current":-7.612205,"twenty":-13.774759,"median":-10.284647,"eighty":-6.025423,"marketCap":1047783588},{"date":"2025-01-31","current":-6.977006,"twenty":-13.765434,"median":-10.25901,"eighty":-6.034301,"marketCap":961552951},{"date":"2025-02-07","current":-7.219276,"twenty":-13.753463,"median":-10.232674,"eighty":-6.052543,"marketCap":990296497},{"date":"2025-02-14","current":-6.822516,"twenty":-13.740454,"median":-10.115609,"eighty":-6.061351,"marketCap":942029033},{"date":"2025-02-21","current":-6.467941,"twenty":-13.734308,"median":-10.093087,"eighty":-6.062421,"marketCap":894846232},{"date":"2025-02-28","current":-6.133931,"twenty":-13.727465,"median":-10.02417,"eighty":-6.065143,"marketCap":843867113},{"date":"2025-03-07","current":-5.852269,"twenty":-13.71316,"median":-9.970579,"eighty":-6.049778,"marketCap":837901472},{"date":"2025-03-14","current":-6.385184,"twenty":-13.708332,"median":-9.910974,"eighty":-6.026825,"marketCap":917081805},{"date":"2025-03-21","current":-5.844642,"twenty":-13.700767,"median":-9.829627,"eighty":-6.025288,"marketCap":838443803},{"date":"2025-03-28","current":-5.916884,"twenty":-13.679442,"median":-9.795031,"eighty":-5.984934,"marketCap":844409444},{"date":"2025-04-04","current":-5.41793,"twenty":-13.665275,"median":-9.712775,"eighty":-5.969,"marketCap":792887995},{"date":"2025-04-11","current":-4.319691,"twenty":-13.654878,"median":-9.636637,"eighty":-5.953745,"marketCap":648468389},{"date":"2025-04-17","current":-4.898467,"twenty":-13.65194,"median":-9.603412,"eighty":-5.931936,"marketCap":747645908},{"date":"2025-04-25","current":-5.660159,"twenty":-13.648303,"median":-9.484661,"eighty":-5.916884,"marketCap":862626437},{"date":"2025-05-02","current":-6.426634,"twenty":-13.611466,"median":-9.396394,"eighty":-5.918352,"marketCap":972702584},{"date":"2025-05-09","current":-6.135697,"twenty":-13.604729,"median":-9.345786,"eighty":-5.927903,"marketCap":928563139},{"date":"2025-05-16","current":-5.081075,"twenty":-13.598948,"median":-9.280564,"eighty":-5.916884,"marketCap":866985889},{"date":"2025-05-23","current":-5.189286,"twenty":-13.570194,"median":-9.208581,"eighty":-5.882056,"marketCap":893142597},{"date":"2025-05-30","current":-5.256736,"twenty":-13.527456,"median":-9.173722,"eighty":-5.851134,"marketCap":911125334},{"date":"2025-06-06","current":-5.007101,"twenty":-13.509055,"median":-9.060878,"eighty":-5.837961,"marketCap":874614929},{"date":"2025-06-13","current":-5.317982,"twenty":-13.49872,"median":-8.982791,"eighty":-5.819476,"marketCap":938916836},{"date":"2025-06-20","current":-5.183436,"twenty":-13.485895,"median":-8.943559,"eighty":-5.800161,"marketCap":906765882},{"date":"2025-06-27","current":-5.465947,"twenty":-13.472919,"median":-8.879507,"eighty":-5.782121,"marketCap":975427241},{"date":"2025-07-03","current":-5.649134,"twenty":-13.4687,"median":-8.851321,"eighty":-5.729733,"marketCap":1013572441},{"date":"2025-07-11","current":-6.060959,"twenty":-13.466131,"median":-8.823918,"eighty":-5.695738,"marketCap":1080599005},{"date":"2025-07-18","current":-7.314861,"twenty":-13.46266,"median":-8.816193,"eighty":-5.710767,"marketCap":1293122259},{"date":"2025-07-25","current":-7.006501,"twenty":-13.460198,"median":-8.785147,"eighty":-5.721214,"marketCap":1257999997},{"date":"2025-08-01","current":-8.237689,"twenty":-13.451559,"median":-8.722056,"eighty":-5.729733,"marketCap":1437436162},{"date":"2025-08-08","current":-8.281316,"twenty":-13.442628,"median":-8.688191,"eighty":-5.747092,"marketCap":1469250645},{"date":"2025-08-15","current":-8.47781,"twenty":-13.428755,"median":-8.660023,"eighty":-5.769982,"marketCap":1662306709},{"date":"2025-08-22","current":-8.638654,"twenty":-13.403956,"median":-8.63053,"eighty":-5.780372,"marketCap":1688336740},{"date":"2025-08-29","current":-8.414646,"twenty":-13.396944,"median":-8.638654,"eighty":-5.787092,"marketCap":1651460863},{"date":"2025-09-05","current":-8.112917,"twenty":-13.396458,"median":-8.622065,"eighty":-5.790869,"marketCap":1589278011},{"date":"2025-09-12","current":-8.597222,"twenty":-13.393909,"median":-8.60362,"eighty":-5.797709,"marketCap":1699182587},{"date":"2025-09-19","current":-8.94501,"twenty":-13.385494,"median":-8.610019,"eighty":-5.800038,"marketCap":1774380454},{"date":"2025-09-26","current":-9.045131,"twenty":-13.370479,"median":-8.627645,"eighty":-5.80289,"marketCap":1777272680},{"date":"2025-10-03","current":-8.512022,"twenty":-13.360301,"median":-8.638654,"eighty":-5.813948,"marketCap":1676044781},{"date":"2025-10-10","current":-8.486281,"twenty":-13.357847,"median":-8.622235,"eighty":-5.817225,"marketCap":1651460863},{"date":"2025-10-17","current":-8.047023,"twenty":-13.353429,"median":-8.597222,"eighty":-5.821028,"marketCap":1580601334},{"date":"2025-10-24","current":-8.513119,"twenty":-13.347233,"median":-8.60362,"eighty":-5.824758,"marketCap":1663029766}],"updateTime":1761473010129},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PHVS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553141210","title":"US Stock Futures Edge Higher in Wednesday's Premarket Ahead of Housing, Oil Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2553141210","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553141210?lang=en_us&edition=fundamental","pubTime":"2025-07-23 20:06","pubTimestamp":1753272376,"startTime":"0","endTime":"0","summary":"US stock futures are trending slightly higher in Wednesday's premarket session ahead of housing and oil inventories data scheduled later in the morning.The Dow Jones Industrial Average futures were up","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK4023","LAW","LU1983260115.SGD","LU0738911758.USD","LU0557290698.USD","LU1046421795.USD","LU1235294995.USD","LU0545039389.USD","BK4007","BK4567","BK4588","LU1674673691.USD","ABVX","BK4139","BK4605","LU2129689514.USD","LU1721428933.USD","LU2413666426.HKD","SG9999011175.SGD","BK4534","BK4096","LU2129689431.USD","LU2133065610.SGD","LU1244550577.SGD","BK4585","IE00BZ199S13.USD","LU0553294199.USD","LU0868494617.USD","BK4554","IE0009356076.USD","BK4533","LU0661504455.SGD","PAPL","LU1244550494.USD","LU0314104364.USD","LAW.AU","LU2413666699.HKD","PHVS","LU0345774631.USD","IE00BYQQ9H92.USD","BK7091","TXN","LU0949170772.SGD","LU1003077747.HKD","LU0347712357.USD","IE00BFXG0V08.USD","BK4512","VICR","BK4561"],"gpt_icon":0},{"id":"2553262206","title":"BRIEF-Pharvaris Prices Upsized $175 Million Public Offering Of Ordinary Shares, Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2553262206","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553262206?lang=en_us&edition=fundamental","pubTime":"2025-07-23 09:27","pubTimestamp":1753234060,"startTime":"0","endTime":"0","summary":"BRIEF-Pharvaris Prices Upsized $175 Million Public Offering Of Ordinary Shares, Pre-Funded WarrantsJuly 22 (Reuters) - Pharvaris NV PHVS.O:PHARVARIS ANNOUNCES PRICING OF UPSIZED $175 MILLION PUBLIC OF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nFWN3TJ1PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2553261229","title":"Stocks to Watch: Lulu's, Manhattan Associates, Pharvaris, Usana Health Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2553261229","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553261229?lang=en_us&edition=fundamental","pubTime":"2025-07-23 07:45","pubTimestamp":1753227900,"startTime":"0","endTime":"0","summary":"Lulu's Fashion Lounge regained compliance with the Nasdaq's minimum bid price requirement. The stock soared 46% to $6.39 after the market closed on Tuesday.Manhattan Associates beat Wall Street's expectations for its second-quarter earnings and revenue. Shares gained 11% to $225.Pharvaris proposed a $150 million underwritten public offering. Shares fell 7% to $21.50 in after-hours trading.Usana Health Sciences posted an 11% increase in second-quarter revenue and a jump in adjusted earnings per share. Shares popped 17% to $36.90 after the bell.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4183","IE00BLDYK493.USD","PHVS","MANH","USNA","IE00B64QTZ34.USD","BK4094","BK4122","BK4007","LVLU","LU0390134368.USD","BK4023"],"gpt_icon":0},{"id":"2553261575","title":"Pharvaris Stock Falls on Plans for $150M Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2553261575","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553261575?lang=en_us&edition=fundamental","pubTime":"2025-07-23 06:35","pubTimestamp":1753223700,"startTime":"0","endTime":"0","summary":"Shares of Pharvaris declined after the company announced a proposed $150 million underwritten public offering.The stock slid 9.3% to $20.98 in after-hours trading on Tuesday. Shares have risen 21% year to date.The biopharmaceutical company said Tuesday it intends to grant the offering's underwriters a 30-day option to purchase up to an additional $22.5 million in ordinary shares.Pharvaris did not disclose the expected price per share or timing of the offering.The company said it intends to use the net proceeds from the offering to fund research and development expenses for its late-stage clinical programs and hire a sales and marketing team in the U.S., as well as for working capital and general corporate purposes.Morgan Stanley, Leerink Partners, Cantor, Oppenheimer and Van Lanschot Kempen are acting as joint book-running managers, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","BK4534","LU1074936037.SGD","LU2357305700.SGD","LU1732799900.SGD","LU2023251221.USD","LU0106261372.USD","LU2089283258.USD","LU0006306889.USD","LU1548497426.USD","LU0267386448.USD","BK4588","LU1162221912.USD","BK4127","LU1720051108.HKD","PHVS","LU0795875169.SGD","LU0225283273.USD","BK4007","LU1720051017.SGD","LU0912757837.SGD","LU2347655156.SGD","LU2271345857.HKD","LU1668664300.SGD","LU1989772923.USD","LU0106831901.USD","LU2111349929.HKD","LU0234570918.USD","LU0158827781.USD","LU2133065610.SGD","LU1732800096.USD","LU0795875086.SGD","LU1989772840.SGD","BK4504","BK4585","BK4516","IE00BKVL7J92.USD","LU0314104364.USD","LU0320765646.SGD","LU0971096721.USD","BK4581","LU1363072403.SGD","LU0098860793.USD","LU2028103732.USD","LU2089284900.SGD","LU0158827948.USD"],"gpt_icon":0},{"id":"2553632932","title":"Pharvaris NV Announces $150 Million Public Offering of Ordinary Shares to Support Clinical Programs and Expansion Efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=2553632932","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553632932?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:05","pubTimestamp":1753214716,"startTime":"0","endTime":"0","summary":"Pharvaris NV, a late-stage biopharmaceutical company specializing in oral bradykinin B2 receptor antagonists for bradykinin-mediated diseases, has announced its intention to offer and sell $150 million of ordinary shares in an underwritten public offering. The offering will be conducted by joint book-running managers Morgan Stanley, Leerink Partners, Cantor, Oppenheimer & Co., and Van Lanschot Kempen. Pharvaris also plans to grant underwriters a 30-day option to purchase an additional $22.5 million of shares. The net proceeds are intended to fund research and development for late-stage clinical programs, establish a sales and marketing team in the U.S., cover related commercialization expenses, and for general corporate purposes. The offering is contingent on market conditions, and there is no assurance on its completion or the final terms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL94fHfs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU2111349929.HKD","LU0912757837.SGD","LU0795875086.SGD","LU0106261372.USD","IE00BKVL7J92.USD","LU0971096721.USD","LU1363072403.SGD","LU0314104364.USD","LU2089283258.USD","BK4127","BK4112","IE00BGHQF748.EUR","LU1989772923.USD","LU2023251221.USD","BK4534","LU1668664300.SGD","LU2028103732.USD","LU0795875169.SGD","LU2095319765.USD","LU0225283273.USD","BK4585","LU0234570918.USD","IE00B64PRP62.GBP","LU2133065610.SGD","LU0098860793.USD","LU0320765646.SGD","LU1732799900.SGD","LU0267386448.USD","BK4581","LU0158827781.USD","LU0106831901.USD","LU2210149790.SGD","IE00BKPKM429.USD","LU1720051108.HKD","BK4516","LU2357305700.SGD","LU0006306889.USD","LU0158827948.USD","PHVS","LU1162221912.USD","LU1720051017.SGD","LU2347655156.SGD","OPY","LU2089284900.SGD","LU1074936037.SGD","IE00BZ1G4Q59.USD","LU1548497426.USD","BK4504","LU2210150020.SGD"],"gpt_icon":0},{"id":"2553883265","title":"Pharvaris Announces Proposed Public Offering of Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2553883265","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553883265?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:05","pubTimestamp":1753214700,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland, July  22, 2025  (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/22/3119831/0/en/Pharvaris-Announces-Proposed-Public-Offering-of-Ordinary-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","LU0012050646.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU1162221912.USD","LU2133065610.SGD","IE00B64QTZ34.USD","LU1720051108.HKD","BK4198","LU1548497426.USD","LU2111349929.HKD","USA","LU2028103732.USD","BK4127","LU0795875086.SGD","LU0106261372.USD","LU0205194284.USD","LU0106831901.USD","BK4534","LU0225283273.USD","LU2089283258.USD","LU1668664300.SGD","LU0267386448.USD","LU1720051017.SGD","LU1169590202.USD","LU0912757837.SGD","LU0158827948.USD","BK4585","BK4581","LU0158827781.USD","LU2271345857.HKD","HAE","LU1363072403.SGD","LU2089284900.SGD","LU2023251221.USD","LU2347655156.SGD","BK4504","LU2357305700.SGD","LU1989772923.USD","LU1732799900.SGD","LU1732800096.USD","LU0314104364.USD","IE00BLDYK493.USD","BK4516","BK4588","PHVS","LU0320765646.SGD","LU0971096721.USD","LU0205193047.USD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2552969172","title":"Pharvaris NV Concluded Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2552969172","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552969172?lang=en_us&edition=fundamental","pubTime":"2025-07-17 10:34","pubTimestamp":1752719652,"startTime":"0","endTime":"0","summary":"Pharvaris NV held its annual general meeting of shareholders on June 27, 2025. The meeting addressed several proposals, including the adoption of the annual accounts for the financial year 2024, the discharge of the board of directors, and the appointment of auditors. All proposals were approved by the requisite majority.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief on July 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL8Llxfb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2550628687","title":"Pharvaris Expects to Release Topline Data From Phase 3 Hereditary Angioedema Study in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2550628687","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550628687?lang=en_us&edition=fundamental","pubTime":"2025-07-10 20:40","pubTimestamp":1752151218,"startTime":"0","endTime":"0","summary":"Pharvaris  said Thursday it now expects to release in Q4 the topline data from the ongoing phase 3 trial assessing deucrictibant immediate-release capsule for the on-demand treatment of hereditary angioedema, or HAE, attacks.Pending positive data, a new drug application is expected to be submitted with the US Food and Drug Administration in H1 of 2026, the company said.The updated timing is a pull-forward of about one quarter from the previous timing guidance, Wedbush Securities said in a note Thursday.\"We... continue to see [Pharvaris] as uniquely positioned in the HAE space with deucrictibant offering benefit in both the acute and prophylactic settings,\" the firm said.Wedbush maintained the company's outperform rating and $27 price target.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2550641765","title":"BRIEF-Pharvaris NV - Expects Rapide-3 Data Announcement In Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2550641765","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550641765?lang=en_us&edition=fundamental","pubTime":"2025-07-10 18:53","pubTimestamp":1752144801,"startTime":"0","endTime":"0","summary":"BRIEF-Pharvaris NV - Expects Rapide-3 Data Announcement In Q4 2025July 10 (Reuters) - Pharvaris NV PHVS.O:PHARVARIS NV - EXPECTS RAPIDE-3 DATA ANNOUNCEMENT IN Q4 2025PHARVARIS NV - PLANS NDA SUBMISSIO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nFWN3T60R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2550417836","title":"Pharvaris NV to Announce Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2550417836","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550417836?lang=en_us&edition=fundamental","pubTime":"2025-07-10 18:50","pubTimestamp":1752144613,"startTime":"0","endTime":"0","summary":"Pharvaris NV has announced future financial event dates related to their RAPIDe-3 pivotal Phase 3 study. The topline data announcement is expected in the fourth quarter of 2025. Pharvaris plans to submit a New Drug Application  to the U.S. FDA for the on-demand treatment of HAE attacks in the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via GlobeNewswire  on July 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nNDL9Z8wJy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210150020.SGD","BK4588","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","LU2095319765.USD","IE00BGHQF748.EUR","PHVS","IE00B3QW5Z07.USD","BK4007","BK4112"],"gpt_icon":0},{"id":"2546292087","title":"Pharvaris NV Conducted Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2546292087","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546292087?lang=en_us&edition=fundamental","pubTime":"2025-06-28 04:15","pubTimestamp":1751055334,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 27, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDLbMYspq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2546177667","title":"Pharvaris NV to Present Promising Clinical Trial Data on Oral Deucrictibant for Hereditary Angioedema at 2025 US HAEA National Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2546177667","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546177667?lang=en_us&edition=fundamental","pubTime":"2025-06-27 18:50","pubTimestamp":1751021414,"startTime":"0","endTime":"0","summary":"Pharvaris NV to Present Promising Clinical Trial Data on Oral Deucrictibant for Hereditary Angioedema at 2025 US HAEA National Summit. Pharvaris NV, a late-stage biopharmaceutical company, has announced the upcoming presentation of clinical trial data concerning deucrictibant, an oral bradykinin B2 receptor antagonist, for the treatment of hereditary angioedema . The data will be showcased at the US Hereditary Angioedema Association's 2025 National Summit, scheduled from July 10-13 in Baltimore, Maryland. The presentations will cover various aspects of deucrictibant, including its long-term safety and efficacy, its durability of response for on-demand treatment, and a comparison with standard care. These findings will be presented on July 11, 2025, during a poster session. The posters will also be accessible on Pharvaris' website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDLb4Nv0y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","BK4007","IE00BGHQF748.EUR","LU2210150020.SGD","NDAQ","BK4585","IE00B64PRP62.GBP","LU2095319765.USD","PHVS","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4112"],"gpt_icon":0},{"id":"2543799576","title":"Pharvaris Unveils Promising Data on Deucrictibant for Bradykinin-Mediated Angioedema at EAACI Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2543799576","media":"Reuters","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543799576?lang=en_us&edition=fundamental","pubTime":"2025-06-16 18:50","pubTimestamp":1750071021,"startTime":"0","endTime":"0","summary":"Pharvaris NV , a late-stage biopharmaceutical company, has announced the presentation of data at the European Academy of Allergy and Clinical Immunology  Congress 2025, highlighting the potential of deucrictibant in preventing and treating bradykinin-mediated angioedema attacks. The data demonstrated deucrictibant's potential to address unmet needs for individuals with bradykinin-mediated diseases, such as hereditary angioedema  and acquired angioedema due to C1 inhibitor deficiency . The findings from the CHAPTER-1 and RAPIDe-2 studies indicated sustained attack reduction and improvement in quality of life. Additionally, the upcoming RAPIDe-3 phase 3 on-demand study will explore \"end-of-progression\" as a new pre-specified endpoint. Currently, there are no approved therapies for AAE-C1INH attacks, and Pharvaris' research aims to fill this gap. The posters with detailed findings are available on the Pharvaris website.Disclaimer: This news brief was created by Public Technologies  using ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL37n2Yk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NDAQ","PHVS","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","BK4585","IE00BKPKM429.USD","LU2210150020.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4588"],"gpt_icon":0},{"id":"2542589660","title":"Guggenheim Initiates Coverage on Pharvaris With Buy Rating, $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2542589660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542589660?lang=en_us&edition=fundamental","pubTime":"2025-06-11 19:34","pubTimestamp":1749641664,"startTime":"0","endTime":"0","summary":"Pharvaris N.V (PHVS) has an average rating of Buy and mean price target of $33.19, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PHVS"],"gpt_icon":0},{"id":"2542467315","title":"Press Release: Pharvaris Announces Annual Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2542467315","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542467315?lang=en_us&edition=fundamental","pubTime":"2025-06-10 18:50","pubTimestamp":1749552600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland, June 10, 2025  -- Pharvaris , a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema  and acquired angioedema due to C1 inhibitor deficiency , today announced the annual general meeting of shareholders will take place on Friday, June 27, 2025, at 16:00 CEST .All relevant documents and information relating to the annual general meeting, including the notice and agenda for the annual general meeting, are or will be made available in the \"Investors\" section of Pharvaris' website under \"Events & Presentations\". The documents will also be made available on the SEC's website at www.sec.gov. Shareholders who wish to attend the meeting should register as described in the notice and agenda for the annual general meeting.Executive Director, Head of Corporate and Investor Communications","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","LU0205193047.USD","LU1169590202.USD","IE00B64QTZ34.USD","BK4604","HAE","PHVS","IE00BLDYK493.USD","LU0205194284.USD","BK4588","BK4585","LU0106261612.USD","BK4007","LU1169589451.USD","03160","BK4555","BK4198","TM","LU0012050646.USD"],"gpt_icon":0},{"id":"2542353553","title":"Pharvaris NV Publishes 2024 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2542353553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542353553?lang=en_us&edition=fundamental","pubTime":"2025-06-10 06:18","pubTimestamp":1749507526,"startTime":"0","endTime":"0","summary":"Pharvaris N.V. has released its Annual Report for the fiscal year ending December 31, 2024. The report details the company's business activities, organizational structure, and operating results. It highlights the company's ongoing focus on research and development, which has been its principal expenditure since inception. Pharvaris has primarily financed its operations through the issuance of equity securities. The report also covers various risk factors and controls and procedures in place. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information cont","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDLbPJWZw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2541407590","title":"Pharvaris Price Target Maintained With a $27.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2541407590","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541407590?lang=en_us&edition=fundamental","pubTime":"2025-06-05 21:44","pubTimestamp":1749131040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHVS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 05, 2025 09:44 ET (13:44 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS"],"gpt_icon":0},{"id":"2536683418","title":"Pharvaris NV to Present Deucrictibant Clinical and Biomarker Data at C1-Inhibitor Deficiency and Angioedema Workshop","url":"https://stock-news.laohu8.com/highlight/detail?id=2536683418","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536683418?lang=en_us&edition=fundamental","pubTime":"2025-05-19 18:50","pubTimestamp":1747651812,"startTime":"0","endTime":"0","summary":"Pharvaris NV, a late-stage biopharmaceutical company, is set to present at the 14th C1-Inhibitor Deficiency and Angioedema Workshop in Budapest from May 29 to June 1, 2025. The company will share insights on the \"Clinical Validation of a Novel Biomarker Assay to Characterize Bradykinin-Mediated Angioedema in Prospective and Biobank Plasma Samples\" and the \"Long-Term Prophylactic Treatment With Oral Deucrictibant Improves Health-Related Quality of Life and Disease Control in Participants With Hereditary Angioedema: CHAPTER-1 Open-Label Extension Study.\". Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via GlobeNewswire  on May 19, 2025, and is solely responsibl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL1Lbmpq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","BK4588","BK4585","LU2095319765.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4007","BK4112","IE00B64PRP62.GBP","NDAQ","LU2210150020.SGD"],"gpt_icon":0},{"id":"1164894540","title":"Stock Track | Pharvaris N.V. Plummets 5.15% After Q1 Earnings Miss and Conflicting Analyst Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=1164894540","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164894540?lang=en_us&edition=fundamental","pubTime":"2025-05-14 22:58","pubTimestamp":1747234708,"startTime":"0","endTime":"0","summary":"Shares of Pharvaris N.V.  tumbled 5.15% in intraday trading, as investors reacted to the company's disappointing first-quarter earnings report and mixed signals from analysts. The biopharmaceutical company, which focuses on developing novel therapies for hereditary angioedema , faced significant selling pressure following the release of its financial results.Pharvaris reported a quarterly loss of $0.89 per share, missing the analyst consensus estimate of $0.82 by 8.54%. This represents a substan","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PHVS"],"gpt_icon":0},{"id":"1195284900","title":"Stock Track | Pharvaris N.V. Plummets 5.15% After Disappointing Q1 Results and Analyst Price Target Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=1195284900","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195284900?lang=en_us&edition=fundamental","pubTime":"2025-05-14 22:58","pubTimestamp":1747234705,"startTime":"0","endTime":"0","summary":"Shares of Pharvaris N.V.  tumbled 5.15% in intraday trading, as investors reacted to the company's disappointing first-quarter financial results and a subsequent analyst price target reduction.The clinical-stage biopharmaceutical company reported quarterly losses of $0.89 per share, missing the analyst consensus estimate of $0.82 by 8.54%. This represents a significant increase in losses compared to the same period last year when the company reported a loss of $0.56 per share. The wider-than-exp","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Stock Track | Pharvaris N.V. Plummets 5.15% After Disappointing Q1 Results and Analyst Price Target Cut","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PHVS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}]}}